Net Worth Advisory Group’s AstraZeneca AZN Stock Holding History

Net Worth Advisory Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Buy	1,987 +38	+2%	+$7.15K	0.09%	217
2026 Q1	$384K	Buy	1,949 +71	+4%	+$13.7K	0.08%	245
2025 Q4	$345K	Sell	1,878 -327	-15%	-$57.4K	0.07%	277
2025 Q3	$338K	Sell	2,205 -37	-2%	-$5.6K	0.1%	238
2025 Q2	$313K	Buy	2,242 +7	+0.3%	+$981	0.07%	290
2025 Q1	$329K	Sell	2,235 -61	-3%	-$8.83K	0.1%	224
2024 Q4	$301K	Sell	2,296 -52	-2%	-$7.28K	0.09%	247
2024 Q3	$366K	Buy	+2,348	New	+$379K	0.11%	216

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Net Worth Advisory Group's AZN Position: Q2 2026 in Review

Net Worth Advisory Group increased its AstraZeneca (AZN) stake by 1.9% in Q2 2026, buying an estimated $7.15K and bringing the position to 1,987 shares worth $377K. The position accounts for 0.09% of the portfolio, ranked #217.

Net Worth Advisory Group first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $384K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Net Worth Advisory Group held 1,987 shares of AstraZeneca worth $377K as of Q2 2026.
Net Worth Advisory Group bought 38 AstraZeneca shares in Q2 2026, an estimated $7.15K.
AstraZeneca made up 0.09% of Net Worth Advisory Group's portfolio in Q2 2026, its #217 holding.
Net Worth Advisory Group first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's AstraZeneca position peaked at $384K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.